Dasotraline for Adults With Binge Eating Disorder
Researchers compared Dasotraline and placebo, tracking side effects to assess safety and tolerability in adults with binge eating.
Understand this study
What did researchers investigate?
Researchers compared Dasotraline and placebo, tracking side effects to assess safety and tolerability in adults with binge eating.
Who was this study for?
Listed age limits: 18 years to 55 years.
- Listed locations
- Beverly Hills and 42 more locationsSee all locations and recruitment
- Study phase
- Phase 2 / Phase 3This study spans more than one phase, so it may combine goals such as safety, dosing, and early effectiveness.
Study information
- Recruitment status
- Completed
- Enrollment listed in the registry
- 319
- Sponsor
- Sumitomo Pharma America, Inc.
- Sponsor type
- Pharmaceutical company
- Study type
- Drug
- Intervention type
- Drug
- Study phase
- Phase 2 / Phase 3This study spans more than one phase, so it may combine goals such as safety, dosing, and early effectiveness.
- Locations
- United States
- Age range
- From 18 Years to 55 Years
- Official registry ID
- NCT02564588
- Official title
Show the full official title
A 12-week, Randomized, Double-blind, Parallel-group, Placebo Controlled, Flexibly Dosed, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of Dasotraline in Adults With Moderate to Severe Binge Eating Disorder
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
Beverly Hills · Encino · Garden Grove
39 more locations
- Newport Beach
- San Diego
- Santa Ana
- Denver
- Jacksonville
- North Miami
- Orlando
- South Miami
- Alpharetta
- Atlanta
- Libertyville
- Indianapolis
- Wichita
- Belmont
- Watertown
- Saint Charles
- Princeton
- Mount Kisco
- Raleigh
- Akron
- Cincinnati
- Dayton
- Mason
- Middleburg Heights
- Oklahoma City
- Medford
- Portland
- Salem
- Allentown
- Anderson
- Greer
- Dallas
- Houston
- Plano
- Murray
- Ogden
- Woodstock
- Herndon
- Seattle
Interested in joining this study?
Questions about this study
What did researchers investigate?
Researchers compared Dasotraline and placebo, tracking side effects to assess safety and tolerability in adults with binge eating.
Who is behind this study?
The study sponsor is Sumitomo Pharma America, Inc., a pharmaceutical company.
Did this study involve medication?
Yes. The study involved medication, including Dasotraline and Placebo.
Who was this study for?
Listed age limits: 18 years to 55 years.
